We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Report Explores Nanotechnology's Future

By Biotechdaily staff writers
Posted on 02 May 2007
A new report summarizes discussions among over 50 scientists, engineers, ethicists, policymakers, and other experts, as well as information gathered in follow-up interviews and from specially prepared background papers about the long-term potential of nanotechnology.

Controlling the properties and behavior of matter at the smallest scale--in effect, domesticating atoms--can help to overcome some of the world's biggest challenges, concluded the report on how diverse experts view the future of nanotechnology. More...
Written by science writer Karen F. Schmidt, the report examines several compelling opportunities for significant, widespread benefit, focusing on nanotechnology's ability to address the energy crisis, the need for better medical treatments, and the demand for clean water.

The report is the product of a forecasting and awareness-raising activity sponsored by the U.S. National Science Foundation (NSF; Arlington, VA, USA), U.S. National Institutes of Health (NIH; Bethesda, MD, USA), and the Project on Emerging Nanotechnologies (Washington, DC, USA), which is an initiative of the Woodrow Wilson International Center for Scholars (Washington, DC, USA) and The Pew Charitable Trusts (Washington, DC, USA).

Nanotechnology is still developing, with the potential to deliver a range of benefits today and in the future. Most first-generation nanomedicines, according to the report, are reformulations of existing drugs, usually modified to enable new methods of delivery inside the body. Experts predict the creation of novel nanostructures that could serve as new kinds of drugs for treating cancer, Parkinson's, and cardiovascular disease.

Researchers also are working toward engineered nanomaterials for use as artificial tissues that will replace diseased kidneys and livers, and even repair nerve damage. Nanotechnology can be used very effectively to extract critical information about the inception of the disease process at the level of the molecule and the atom, and as such, it presents us with a huge horizon of exploration, NIH director Elias Zerhouni observed at the workshop.

Relevant to nearly every industry, nanotechnology is considered a platform technology, the report stated, because it readily merges and converges with other technologies and could change how we do just about everything. The report singles out advances in three underpinning technical areas--research tools, information management, and assembly and manufacturing--as fundamental to progress across the entire spectrum of nanotechnology research and development needs.


Related Links:
National Science Foundation
National Institutes of Health
Project on Emerging Nanotechnologies

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.